Oncopeptides AB - Stocks

Compare with Oncopeptides AB



Market capitalization

‪664.72 M‬ SEK

—

—

−0.845 SEK

‪−249.59 M‬ SEK

‪71.12 M‬ SEK

‪295.87 M‬

Beta (1Y)

−0.18

Next report date

—

Report period

—

EPS estimate

—

Revenue estimate

—

Employees (FY)

75

Change (1Y)

+9+13.64%

Revenue / Employee (1Y)

‪948.24 K‬ SEK

Net income / Employee (1Y)

‪−3.33 M‬ SEK

Company info



Sector

Industry

CEO

Sofia Heigis

Website

Headquarters

Stockholm

Founded

2000

IPO date

Feb 22, 2017

ISIN

SE0009414576

FIGI

BBG00FYBPDP1

Identifiers

ISIN SE0009414576

CFI code

ESVUFR

Oncopeptides AB is a pharmaceutical company, which is involved in the development of targeted therapies for hematological diseases. The firm focuses on its product candidate melflufen, a peptide conjugated alkylator, belonging to a new class of drugs called peptidase enhanced cytotoxics, which targets aminopeptidases and rapidly releases alkylating agents into tumor cells. The company was founded by Rolf Larsson, Rolf Lewensohn, Joachim Gullbo, Kristina Luthman, Hans Ehrsson, and Peter Nygren on September 5, 2000 and is headquartered in Stockholm, Sweden.

Performance

Revenue to profit conversion

Debt level and coverage

Earnings

Next:—

Summarizing what the indicators are suggesting.

Neutral

SellBuy

Strong sellStrong buy

Strong sellSellNeutralBuyStrong buy

Neutral

SellBuy

Strong sellStrong buy

Strong sellSellNeutralBuyStrong buy

Neutral

SellBuy

Strong sellStrong buy

Strong sellSellNeutralBuyStrong buy

An aggregate view of professional's ratings.

Neutral

SellBuy

Strong sellStrong buy

Strong sellSellNeutralBuyStrong buy

Neutral

SellBuy

Strong sellStrong buy

Strong sellSellNeutralBuyStrong buy

Neutral

SellBuy

Strong sellStrong buy

Strong sellSellNeutralBuyStrong buy

Displays a symbol's price movements over previous years to identify recurring trends.

Frequently asked questions



The current price of ONCO is 1.676 SEK — it has decreased by −3.90% in the past 24 hours. Watch Oncopeptides AB stock price performance more closely on the chart.

Depending on the exchange, the stock ticker may vary. For instance, on OMXSTO exchange Oncopeptides AB stocks are traded under the ticker ONCO.

ONCO stock has risen by 6.62% compared to the previous week, the month change is a 3.20% rise, over the last year Oncopeptides AB has showed a −55.19% decrease.

We've gathered analysts' opinions on Oncopeptides AB future price: according to them, ONCO price has a max estimate of 3.10 SEK and a min estimate of 2.00 SEK. Watch ONCO chart and read a more detailed Oncopeptides AB stock forecast: see what analysts think of Oncopeptides AB and suggest that you do with its stocks.

ONCO reached its all-time high on Mar 1, 2021 with the price of 136.276 SEK, and its all-time low was 0.978 SEK and was reached on Mar 18, 2025. View more price dynamics on ONCO chart.
See other stocks reaching their highest and lowest prices.

ONCO stock is 4.85% volatile and has beta coefficient of −0.18. Track Oncopeptides AB stock price on the chart and check out the list of the most volatile stocks — is Oncopeptides AB there?

Today Oncopeptides AB has the market capitalization of ‪664.72 M‬, it has increased by 12.04% over the last week.

Oncopeptides AB is going to release the next earnings report on Aug 27, 2026. Keep track of upcoming events with our Earnings Calendar.

ONCO net income for the last quarter is ‪−32.19 M‬ SEK, while the quarter before that showed ‪−65.17 M‬ SEK of net income which accounts for 0.00% change. Track more Oncopeptides AB financial stats to get the full picture.

No, ONCO doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.

As of Aug 22, 2026, the company has 75 employees. See our rating of the largest employees — is Oncopeptides AB on this list?

Like other stocks, ONCO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Oncopeptides AB stock right from TradingView charts — choose your broker and connect to your account.

Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Oncopeptides AB technincal analysis shows the buy rating today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Oncopeptides AB stock shows the sell signal. See more of Oncopeptides AB technicals for a more comprehensive analysis.